Target intelligence / Profile preview

HIV-1 envelope glycoprotein gp120–gp41 interface

Molecular classification
Viral fusion protein complex, Viral envelope glycoprotein complex, Class I viral fusion machinery (Env trimer composed of gp120 and gp41)
01

Overview

The HIV-1 envelope glycoprotein gp120–gp41 interface is the interaction region between the surface subunit gp120 and the transmembrane subunit gp41 of the HIV-1 envelope spike (Env) complex. This trimeric structure is crucial for HIV-1 cell entry, mediating viral attachment via gp120 binding to the host CD4 receptor and chemokine co-receptors, followed by gp41-driven viral–cell membrane fusion. The interface is a dynamic, structurally complex region and a critical target for broadly neutralizing antibodies and fusion inhibitors, but its high degree of conformational plasticity and glycan shielding make it challenging for vaccine and drug design. Therapies targeting this site aim to block the entry process and prevent HIV-1 infection, but viral escape remains a major challenge.

Other names
HIV-1 Env trimer interfaceHIV-1 envelope glycoprotein interfaceHIV-1 gp120–gp41 quaternary interfaceHIV-1 envelope spike interface
02

Mechanism of action

Inhibitor peptides (e.g., enfuvirtide) block refolding of gp41, preventing membrane fusion. Monoclonal antibodies bind to quaternary epitopes at the gp120–gp41 interface, blocking conformational changes required for fusion or neutralizing the virus. Some small molecules disrupt the conformational transitions needed for fusion (rare, mostly experimental)

03

Biological functions

Mediates viral entry into host cells via membrane fusionFacilitates attachment to host cell receptors (CD4 and chemokine co-receptors)Immune evasion through conformational masking and glycan shielding
04

Disease associations

Infection (HIV-1/AIDS)Immune evasion (facilitating persistent viral infection)
05

Safety considerations

Immune escape: The interface is highly conformationally flexible and exhibits glycan shielding, leading to rapid viral mutational escape during therapeutic targetingIncomplete neutralization: Some antibodies targeting the interface show only partial efficacy against diverse strains due to heterogeneity or limited epitope accessibilityEnvelope-mediated cytopathic effects: Env expression can induce toxicity in host cells
06

Interacting drugs

Ibalizumab (non-competitive post-attachment inhibitor; targets CD4-induced gp120 conformation)

2 more in the full profile.

07

Biomarkers

Not generally used clinically as specific biomarkers, but presence and abundance of Env or its cleaved forms (gp120/gp41) are used in research and vaccine designViral sensitivity or resistance to bNAbs mapped to mutations at the gp120–gp41 interface

Beyond the preview

Go deeper on HIV-1 envelope glycoprotein gp120–gp41 interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 envelope glycoprotein gp120–gp41 interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call